Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Iradimed Cp (IRMD)

Iradimed Cp (IRMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 203,950
  • Shares Outstanding, K 11,157
  • Annual Sales, $ 30,440 K
  • Annual Income, $ 6,300 K
  • 60-Month Beta 1.64
  • Price/Sales 6.74
  • Price/Cash Flow 31.64
  • Price/Book 4.59

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.12
  • Number of Estimates 1
  • High Estimate 0.12
  • Low Estimate 0.12
  • Prior Year 0.11
  • Growth Rate Est. (year over year) +9.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.68 +9.59%
on 07/15/19
21.96 -16.75%
on 06/24/19
-3.28 (-15.21%)
since 06/19/19
3-Month
16.68 +9.59%
on 07/15/19
29.80 -38.66%
on 04/26/19
-7.81 (-29.93%)
since 04/18/19
52-Week
16.68 +9.59%
on 07/15/19
38.78 -52.86%
on 10/01/18
-4.37 (-19.29%)
since 07/19/18

Most Recent Stories

More News
Iradimed Corp Shares Down 30.0% Since SmarTrend's Sell Call (IRMD)

SmarTrend identified a Downtrend for Iradimed Corp (NASDAQ:IRMD) on April 30th, 2019 at $26.32. In approximately 3 months, Iradimed Corp has returned 29.96% as of today's recent price of $18.43.

IRMD : 18.28 (-0.60%)
IRADIMED CORPORATION to Hold 2019 Second Quarter Financial Results Conference Call on July 30th

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 second quarter financial results before the market opens on Tuesday, July 30. iRadimed management will host a...

IRMD : 18.28 (-0.60%)
Shares of IRMD Down 25.6% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Iradimed Corp (NASDAQ:IRMD) on April 30th, 2019 at $26.31. In approximately 2 months, Iradimed Corp has returned 25.59% as of today's recent price of $19.58.

IRMD : 18.28 (-0.60%)
Iradimed Corp Down 24.9% Since SmarTrend Downtrend Call (IRMD)

SmarTrend identified a Downtrend for Iradimed Corp (NASDAQ:IRMD) on April 30th, 2019 at $26.31. In approximately 2 months, Iradimed Corp has returned 24.95% as of today's recent price of $19.75.

IRMD : 18.28 (-0.60%)
Iradimed Corp Down 10.9% Since SmarTrend Downtrend Call (IRMD)

SmarTrend identified a Downtrend for Iradimed Corp (NASDAQ:IRMD) on April 30th, 2019 at $26.32. In approximately 2 weeks, Iradimed Corp has returned 10.91% as of today's recent price of $23.44.

IRMD : 18.28 (-0.60%)
IRADIMED CORPORATION Announces First Quarter 2019 Financial Results

-- Reports first quarter 2019 revenue of $8.4 million

IRMD : 18.28 (-0.60%)
IRADIMED CORPORATION to Hold 2019 First Quarter Financial Results Conference Call on April 30th

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 first quarter financial results before the market opens on Tuesday, April 30. IRADIMED management will host a...

IRMD : 18.28 (-0.60%)
Report: Developing Opportunities within Noble Energy, American Vanguard, Calyxt, Medallion Financial, iRadimed, and Stewart Information Services -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Noble Energy Inc. (NYSE:NBL),...

IRMD : 18.28 (-0.60%)
STC : 38.33 (-3.72%)
NBL : 21.19 (+1.68%)
CLXT : 10.25 (+1.18%)
MFIN : 5.08 (-9.77%)
IRMTF : 11.9721 (-0.40%)
AVD : 14.64 (+0.07%)
IRADIMED CORPORATION Announces FDA 510(k) Clearance for Neonatal Pulse Oximetry and Capnography Monitoring Using its MRI-Compatible Patient Vital Signs Monitor

IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received FDA 510(k) clearance for neonatal use of the pulse oximetry ("SpO2") and Capnography ("CO2") monitoring features of its 3880 Magnetic...

IRMD : 18.28 (-0.60%)
IRADIMED (IRMD) Q4 Earnings Surpass Estimates, Margins Up

IRADIMED (IRMD) reports growth across all operating segments and geographies

IRMD : 18.28 (-0.60%)
ABT : 87.49 (-0.31%)
ANGO : 21.19 (-1.58%)
CNMD : 84.29 (-2.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade IRMD with:

Business Summary

iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump...

See More

Key Turning Points

2nd Resistance Point 19.16
1st Resistance Point 18.72
Last Price 18.28
1st Support Level 17.97
2nd Support Level 17.66

See More

52-Week High 38.78
Fibonacci 61.8% 30.34
Fibonacci 50% 27.73
Fibonacci 38.2% 25.12
Last Price 18.28
52-Week Low 16.68

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar